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The reduction of a series of 2,5-bis(l-aziridinyl)-1,4- 
benzoquinone (BABQ) derivatives with various 3,6 
substituents by the enzyme xanthine oxidase has been 
studied. The reduction rate has been assayed by mea- 
suring the rate of reduction of cytochrome c, which is 
very efficiently reduced by reduced BABQ species. Un- 
der nitrogen, the reduction rate correlated with the 
quinone reduction potential and steric parameters. 
Comparing reduction rates under nitrogen and air 
demonstrates that at BABQ concentrations > 25 j.tM the 
competition for electrons from xanthine oxidase be- 
tween oxygen and the BABQ derivative is dominated 
by the latter. This is also confirmed by the effect of su- 
peroxide dismutase (SOD): in the presence of a BABQ 
derivative, cytochrome c reduction can be totally in- 
hibited by SOD, although the required amount of SOD 
depends on the redox potential of the quinones. This in- 
dicates that SOD causes the equilibrium between semi- 
quinone and superoxide to shift, resulting in a decrease 
of the semiquinone concentration. It is concluded that 
reduction by xanthine oxidase is a simple and effective 
method for reducing aziridinylbenzoquinones. Q 1990 
Academic Press, Inc. 
Many important drugs used in anticancer therapy 
contain a quinone moiety. Mitomycin C and bis(l- 
aziridinyl)benzoquinone derivatives, such as diazi- 
quone(AZQ),’ are reductively activated alkylating drugs 
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containing a quinone moiety (1, 2). Based on AZQ and 
related compounds (3) we synthesized and studied the 
DNA alkylating properties of a series of bis( 1-aziridinyl) 
benzoquinones (4). 
Quinone-containing compounds can be reduced in two 
successive one-electron steps. Reoxidation of a reduced 
quinone species can yield superoxide anion and other re- 
lated reactive oxygen species (redox cycling) (5). Pro- 
duction of reduced oxygen species can be regarded as an 
unwanted side effect of reductively activated alkylating 
drugs. 
In our previous studies (4,6) we used NaBH, and elec- 
trochemical reduction to activate the quinones. How- 
ever, to study redoxcycling, enzymatic reduction is pre- 
ferred, to let the quinones undergo multiple reduction- 
reoxidation cycles in the presence of oxygen. 
In this paper we report on the use of xanthine oxidase 
for reductive activation of aziridinylbenzoquinones, us- 
ing xanthine as an electron donor. Xanthine oxidase is 
frequently used as a source of superoxide radicals (7,8). 
However, quinones are reported to be excellent electron 
acceptors from xanthine oxidase (9). Under physiologi- 
cal circumstances, xanthine oxidase appears to function 
as a NAD-dependent dehydrogenase, but during isola- 
tion it becomes an 02-utilizing oxidase, capable of reduc- 
ing a wide range of substrates (9). Xanthine oxidase is 
found in mammalian liver microsomes (10) and is likely 
to be active in tumor cells (11). Xanthine oxidase is also 
one of the reductive enzymes found in nuclei (12), at the 
site where damage to nuclear DNA may occur (13). 
An important point of concern in using xanthine oxi- 
dase as an activating enzyme for quinones is the possibil- 
ity of simultaneous reduction of molecular oxygen (lead- 
ing to superoxide) and reduction of quinone derivatives 
by the enzyme. 
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TABLE I 
General Structure of 2,5-bis(l-aziridinyl)-1,4-Benzoquinone 
and Structures of Derivatives 
R2 O NY 
a 
I I 
P” o R1 
BABQ derivative RI R2 
TW19 F F 
TW13 H H 
TW14 Cl Cl 
Diaziquone (AZQ) NHCOOCsH, NHCOOC2HS 
Carboquone C& CH(OCHz)CHPOCONH, 
TW22 Br ‘=a 
TW25 Br GHs 
TW39 f.X CH,CH,OCONH, 
TW34 N(CHs)C2H40H N(CHs)C2H40H 
TW32 Cb GHs 
In this study, we used ferricytochrome c to determine 
the reduction rate of a series of 2,5-bis(l-aziridinyl)-1,4- 
benzoquinone (BABQ) derivatives by xanthine oxidase. 
We report a structure-activity relationship between the 
reduction rates of the BABQ derivatives by xanthine ox- 
idase and electrochemical and steric parameters. By 
comparing cytochrome c reduction under air and under 
nitrogen, we demonstrate that a competition exists for 
xanthine oxidase between molecular oxygen and BABQ 
derivatives: at BABQ concentrations > 25 PM electron 
transfer from xanthine oxidase to oxygen is practically 
completely inhibited in favor of electron transfer to 
BABQ. The position of the equilibrium between reduced 
BABQ and superoxide is studied with use of superoxide 
dismutase (SOD) and compared with the redox poten- 
tials of the BABQ derivatives. 
MATERIALS AND METHODS 
The structures of the BABQ compounds are described in Table I. 
TW13, TW25, TW32, and TW39 were prepared as described pre- 
viously (4). TW14 (14), TW19 (15), and TW22 (16) were prepared as 
described in the literature. TW34 was a gift from Dr. J. S. Driscoll, 
Drug Research and Development Division of Cancer Treatment, Na- 
tional Institutes of Health, Bethesda, Maryland. Diaziquone was a gift 
from the Drug Synthesis and Chemistry Branch, National Cancer In- 
stitute, Maryland. Carboquone was a gift from the Chemical Research 
Laboratories, Sankyo Co., Ltd, Tokyo, Japan. The purity of all com- 
pounds was tested by HPLC analysis. Stock solutions of the BABQ 
derivatives contained 5 mM BABQ in N,N-dimethylformamide 
(DMF) and were kept at -20°C. 1,4 Benzoquinone (1,4-BQ) was from 
Aldrich Europe, Beerse, Belgium. 
Catalase (from beef liver, EC 1.11.1.6, 20 mg.mll’, 65,000 U.mg-‘) 
and superoxide dismutase (from bovine erythrocytes, EC 1.15.1.1., 
5000 U.mg-‘) were from Boehringer Mannheim GmbH. The SOD 
stock solution contained 600 U SOD/ml. Cytochrome c (Type III, from 
horse heart), xanthine (sodium salt), xanthine oxidase (Grade III, 
from buttermilk, EC 1.2.3.2, 15.4 II. ml-‘, 1.2 U/mg protein), and eth- 
ylenediamine tetraacetic acid (EDTA, disodium salt) were from Sigma 
Chemical Company, St. Louis, Missouri. Na2HPOI.2H,0 and 
KHZPO,, analytical grade, were from Fluka AG, Buchs, Switzerland. 
iV,N-Dimethylformamide was from Merck. 
Absorbances were measured on a Perkin-Elmer Lambda 5 spectro- 
photometer. Polarograms were recorded in a vessel kept at 25”C, using 
a PAR 310 polarographic detector (Princeton Applied Research, 
Princeton, NJ) and a PAR Model 174 polarographic analyzer. 
Correlations were calculated using Statgraphics statistical program 
(Statistical Graphics Corporation/STSC Inc.). Lineweaver-Burk ki- 
netics were calculated using a nonlinear data analysis program (Enz- 
fitter, Elsevier Biosoft). 
Measurement of cytochrome c reduction. BABQ stock solution was 
added to a thermostated solution at 25”C, containing 20 FM cyto- 
chrome c, 50 pM xanthine, and 100 pM EDTA in 50 mM phosphate 
buffer, pH 7.5, to obtain the indicated concentrations of the BABQ 
derivative. For experiments under nitrogen, the solution was purged 
by passing nitrogen through the solution for 15 min, which was enough 
to suppress the production of superoxide by xanthine oxidase. The 
reaction was started by adding xanthine oxidase to obtain a final con- 
centration of 2 mu/ml. After bubbling nitrogen through the solution 
for another 30 s, nitrogen was passed over the solution and the in- 
crease of absorbance at 418 nm was recorded for 10 min. The slope 
of the absorbance increase was initially linear. The concentration of 
reduced cytochrome c was obtained using a molar absorptivity (e) of 
70,000 liter. mall’ cm-’ at 418 nm (17). 
For experiments under air the same procedure was followed, omit- 
ting the flushing with nitrogen. 
Measurement of xanthine oxidation. To estimate the efficiency of 
the electron transport from xanthine via the reduced BABQ derivative 
to cytochrome c, the oxidation of xanthine was followed spectrophoto- 
metrically. However, uv absorption of oxidized and reduced BABQ 
species heavily influenced these measurements. Therefore, only xan- 
thine oxidation in the presence of TW19, the BABQ derivative with 
the most positive redox potential, was measured. With this compound, 
measurements were performed at 291 nm, which is the isoabsorptive 
point of the oxidized and reduced form of TW19. The difference in 
molar absorptivity between xanthine and uric acid was found to be 
10,500 liter. mall’ . cm-i at 291 nm. 
Effect of SOD on cytochrome c reduction rate. To the solution, as 
described under Measurement of cytochrome c reduction, SOD stock 
solution was added to the indicated concentrations. The cytochrome c 
reduction rate is expressed as the percentage of the reduction rate in 
the absence of SOD. 
Polarographic measurements. Polarograms were recorded from a 
solution containing 500 pM xanthine in 50 mM phosphate buffer, pH 
7.5, to which BABQ stock solution was added to obtain a concentra- 
tion of 10 pM BABQ derivative. The solution was saturated with nitro- 
gen by bubbling nitrogen for I5 min. The reaction was started by add- 
ing xanthine oxidase to obtain a final concentration of 12 mu/ml. 
After bubbling nitrogen through the solution for another 60 s, nitrogen 
was passed over the solution and sampled dc polarograms were re- 
corded at a scan rate of 5 mV. s-l, drop time 1 s. 
RESULTS 
Reduction of Aziridinylquinones by Xanthine Oxidase 
under Nitrogen 
All BABQ derivatives (structures shown in Table I) 
were capable of reducing cytochrome c under nitrogen, 
after reduction by xanthine oxidase. Cytochrome c re- 
duction under nitrogen in the absence of BABQ deriva- 
tives was low (<0.02 PM. mini’). Addition of SOD did 
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FIG. 1. Lineweaver-Burk plots of xanthine oxidation (0) and cyto- 
chrome c reduction (0) under nitrogen, in the presence of TW19 by 
xanthine oxidase in a mixture containing 2 mu. ml-’ xanthine oxi- 
dase, 50 pM xanthine, and 100 pM EDTA in 50 mM phosphate buffer, 
pH 7.5, at 25°C. The samples contained 20 pM cytochrome c. The xan- 
thine oxidation rates are multiplied by a factor of 2 to obtain electronic 
equivalency of xanthine and cytochrome c. 
not influence the cytochrome c reduction rate in the 
presence of BABQ derivatives under nitrogen. 
The reduction rate of cytochrome c in the presence of 
TW19 is compared with the concomitant xanthine oxi- 
dation rate by means of a Lineweaver-Burk plot in Fig. 
1. The lines are not significantly different, which indi- 
cates a very efficient electron transfer from xanthine via 
reduced BABQ derivative to cytochrome c. 
The other BABQ compounds have more negative re- 
dox potentials than TW19 (Table II), and their semiqui- 
none radicals, once formed by xanthine oxidase, are ex- 
pected to reduce cytochrome c with at least the same 
efficiency. Therefore, the cytochrome c reduction rate 
under nitrogen can be taken as a direct measure for the 
BABQ reduction rate by xanthine oxidase. 
The obtained reduction rates of a series of BABQ de- 
rivatives (10 PM solutions) are listed in Table II. The 
reduction rates of the BABQ derivatives correlated with 
the half-wave potentials, determined by Driebergen 
et al. (18) and Driebergen (19), as described by Eq. [ 11: 
u,,d = 1.465 + 6.506*&,(V) PI 
n = 10, r2 = 0.71, F = 19.6,p = 0.002. 
The correlation coefficient is greatly improved by in- 
cluding a steric parameter, MRToT, representing the sum 
of substituent values of molar refractivity (20): 
u,,d = 1.799 + 3.978 * Ellz - 0.0159 * MRToT PI 
n = 10, r2 = 0.94, F = 50.0,~ = 0.00007. 
TABLE II 
Cytochrome c Reduction Rates of BABQ Derivatives 
BABQ derivative Em W) M&o-r 
TW19 -0.087 
TW13 -0.105 
TW14 -0.113 
AZQ -0.149 
CbQ -0.182 
TW22 -0.185 
TW25 -0.210 
TW39 -0.213 
TW34 -0.225 
TW32 -0.227 
vred (CC) 
(pM.min-‘) 
28.9 0.99 kO.08 
29.1 0.99 kO.08 
39.1 0.73 +0.12 
69.4 0.028 f 0.015 
60.7 0.005 +_ 0.003 
41.6 0.49 kO.04 
46.2 0.21 f 0.03 
53.9 0.007 f 0.002 
68.8 0.044 k 0.015 
43.0 0.12 i 0.02 
Note. Cytochrome c reduction rates of BABQ derivatives ( u,~ (CC)) 
under nitrogen, in the presence of 10 PM BABQ derivative, 2 mu. ml-’ 
xanthine oxidase, 50 pM xanthine, and 100 pM EDTA in 50 mM phos- 
phate buffer, pH 7.5, at 25°C. Values for ~,~d (CC) are means from at 
least five experiments. El,* = redoxpotential, as determined by Drie- 
bergen (18, 19), MRToT = sum of molar refractivity values of the 2, 3, 
5, and 6 substituents. 
Lineweaver-Burk plots of cytochrome c reduction un- 
der nitrogen in the presence of TW19, TW22, TW25, 
and AZQ are shown in Fig. 2. K,,, values of TW19, TW22, 
and TW25 were in the same range (11-21 PM); the K, 
value for AZQ was 257 & 91 pM. The maximum reduction 
rates obtained from this graph increased in the order 
AZQ(0.7 f 0.3 PM. min-‘) N TW25(0.5 f 0.1 pM- min-‘) 
< TW22(1.4 -t 0.1 pM.min-‘) < TWlg(2.4 + 0.5 PM- 
min-‘). BABQ derivatives that slowly reduce cyto- 
chrome c in the presence of xanthine oxidase also 
showed a slow decrease of the height of the cathodic 
wave in polarograms, indicating slow reduction by xan- 
-0.1 -0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 
l/[BABQ] (.lO -‘I . mol -‘) 
FIG. 2. Lineweaver-Burk plots of cytochrome c reduction rates in 
the presence of TW19 (O), TW22 (O), TW25 (m), and AZQ (0) by 
xanthine oxidase under nitrogen, in a mixture containing 2 mu. ml-’ 
xanthine oxidase, 50 PM xanthine, 20 FM cytochrome c, and 100 PM 
EDTA in 50 mM phosphate buffer, pH 7.5, at 25°C. 
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FIG. 3. Increase of the cytochrome c reduction rate in the presence 
of TW19 (0), TW13 (O), TW25 (m), and AZQ (0) in an aerobic mix- 
ture at 25°C containing 2 mu. mll’ xanthine oxidase, 50 pM xanthine, 
20 pM cytochrome c, and 100 FM EDTA in 50 mM phosphate buffer, 
pH 7.5. 
thine oxidase (results not shown). The order of the com- 
pounds was the same as with the reduction rate of cyto- 
chrome c (Table II). Higher concentrations of xanthine 
oxidase were needed in polarographic experiments than 
in cytochrome c measurements. Adsorption or inactiva- 
tion of xanthine oxidase by mercury may be the cause of 
this. 
Reduction of Aziridinylbenzoquinones by Xanthine 
Oxidase under Air 
To study the influence of oxygen on the cytochrome 
c reduction rate, experiments under air were performed 
with some BABQ derivatives. The results for a number 
of BABQ derivatives are represented in Fig. 3. The cyto- 
chrome c reduction in the presence of BABQ derivatives 
increases markedly compared to the situation where 
xanthine oxidase is incubated without BABQ deriva- 
tives ([BABQ] = 0). The concomitant xanthine oxida- 
tion rates under air and under nitrogen were compared 
for the compound TW19 (Fig. 4). The xanthine oxida- 
tion rate was higher under air than under nitrogen. The 
maximum xanthine oxidation rates as determined from 
Fig. 4 did not differ significantly. Reoxidation of cyto- 
chrome c by HzOz , formed from superoxide that did not 
react with cytochrome c, could influence the results (21). 
However, addition of catalase to the incubation mixture 
to remove hydrogen peroxide did not influence the cyto- 
chrome c reduction rate during the incubation time. 
Effect of SOD on Cytochrome c Reduction Rate under Air 
Figure 5 shows the inhibition of the cytochrome c re- 
duction rate by SOD in the presence of a number of 
BABQ derivatives that differ in Ellz value (see Table II). 
2.0 
h 1 
I  I  I  
-0.1 0.0 0.1 0.2 0.3 0.4 
l/[BABQ] (.lO’” I. mol -‘) 
FIG. 4. Lineweaver-Burk plots of xanthine oxidation in the pres- 
ence of TW19 in a mixture containing 2 mU.mll’ xanthine oxidase, 
50 pM xanthine, 20 pM cytochrome c, and 100 PM EDTA in 50 mM 
phosphate buffer, pH 7.5, at 25”C, under air (0) or nitrogen (0). Obser- 
vations were made at 291 nm, the isosbestic point of reduced/unre- 
duced TW19. Xanthine oxidation rates are represented as described 
in the legend to Fig. 1. 
The inhibition by SOD is plotted as percentage of the 
reduction rate in the absence of SOD. 1,4-Benzoquinone 
was included because of its positive redox potential. 
The cytochrome c reduction under air in the presence 
of 10 PM BABQ derivative could be inhibited completely 
by addition of SOD. Concentrations of SOD needed to 
reduce the cytochrome c reduction rate with 50% 
([SOD]& were obtained from these curves (Table III). 
DISCUSSION 
BABQ derivatives, when reduced by xanthine oxidase, 
are capable of reducing cytochrome c with a high effi- 
100 
0 20 40 60 80 100 
[SOD] (mu . ml-’ ) 
FIG. 5. Inhibition of cytochrome c reduction by superoxide dismu- 
tase in an aerobic mixture containing 2 mu. mll’ xanthine oxidase, 50 
jtM xanthine, 20 pM cytochrome c, 10 pM BABQ derivative, and 100 
pM EDTA in 50 mM phosphate buffer, pH 7.5, at 25°C. (0) 1,4-benzo- 
quinone, (0) TW13, (B) TW22, (0) TW39. 
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TABLE III 
Concentrations of SOD Causing a 50% Decrease in 
Cytochrome c Reduction Rate 
BABQ derivative [SOD50%] (mU.mlI’) Eljz (V) (19) K 
1,4-BQ 117 +0.055 0.000231 
TW13 13 -0.105 0.117 
TW22 25 -0.185 2.65 
TW39 0.94 -0.213 7.88 
None 0.46 
Note. Concentrations of SOD causing a 50% decrease in cytochrome 
c reduction rate, in a mixture containing 10 pM BABQ derivative, 2 
mu. ml-’ xanthine oxidase, 50 pM xanthine, 100 pM EDTA, and 20 fiM 
cytochrome c in 50 mM phosphate buffer, pH 7.5. K is the equilibrium 
constant of Eq. [4], computed with Eq. [5]. 
ciency. The BABQ derivative TW19 investigated in this 
study reduced cytochrome c practically quantitatively 
after reduction by xanthine oxidase (Fig. 1). The other 
compounds have lower redox potentials and are ex- 
pected to react with at least the same efficiency. 
To test whether differences in cytochrome c reduction 
rates under nitrogen were really due to differences in re- 
duction rate by xanthine oxidase, or to differences in 
reactivity of reduced BABQ species with cytochrome c, 
reduction of BABQ derivatives was followed by polarog- 
raphy. The results confirmed that the order of the BABQ 
derivatives with regard to cytochrome c reduction rate 
represented the order of BABQ reduction by xanthine 
oxidase. 
The cytochrome c reduction rate under nitrogen was 
taken as a measure for the reduction rate of BABQ deriv- 
atives by xanthine oxidase. The correlation of the BABQ 
reduction rate with the redox potential and the steric 
parameter MRToT (Eq. [2]) indicates that next to redox 
properties of the quinones, steric factors are also impor- 
tant in enzymatic reductive activation. The K,,, values, 
determined from Fig. 2, increase with MRTOT, indicating 
decreased affinity for xanthine oxidase when larger sub- 
stituents are present. In tumor cells quinones are likely 
to be activated by xanthine oxidase and similarly acting 
enzymes (ll), but other reductive enzymes are present 
and likely to be involved in quinone reduction, especially 
NADPH-dependent cytochrome P450 reductase (22). 
The finding that with xanthine oxidase, aziridinylbenzo- 
quinone compounds with small substituents are more 
efficiently reduced is, however, interesting from the 
viewpoint of drug design, because in an earlier study we 
observed that aziridinylbenzoquinone derivatives with 
small substituents alkylate DNA more efficiently than 
derivatives with large substituents (4). 
When we compare the reduction rates of the BABQ 
derivatives under nitrogen and under air, some conclu- 
sions can be drawn. At a low concentration of BABQ 
derivative (Fig. 4), cytochrome c reduction under air is 
higher than under nitrogen. This indicates that under 
these conditions considerable direct oxygen reduction by 
xanthine oxidase takes place. At a high concentration of 
BABQ derivative, the cytochrome c reduction rates un- 
der nitrogen and air become identical. This means, that 
at higher BABQ concentrations (>25 PM), cytochrome c 
reduction under air is mainly caused by reduced BABQ 
species, and (in the presence of cytochrome c) no sub- 
stantial direct oxygen reduction occurs. 
Xanthine oxidase has been reported to catalyze one- 
electron reduction of daunomycin and related com- 
pounds (23,24,25), leading to semiquinone and superox- 
ide production. A combination of one- and two-electron 
reduction has also been reported (26). The question, 
whether reductive activation is exclusively one-electron 
or mixed, is probably of minor importance in predicting 
semiquinone-mediated superoxide production, because 
semiquinone radicals are known to exist in a dismuta- 
tion equilibrium (Eq. [3]), in which the semiquinone 
(Q:) is in equilibrium with the two-electron reduced qui- 
none ( Q2-) and the oxidized quinone (Q): 
2Q: + Q2- + Q 
This equilibrium can be assumed to be efficiently 
reached with typical rate constants of 107-10’ M-‘.s-’ 
(27). The one-electron reduced semiquinone is in redox 
equilibrium with superoxide (Eq. [4]): 
Q; + 02 * 02 + Q [41 
The position of the redox equilibrium (Eq. [4]) is de- 
pendent on the difference between the redox potential of 
the BABQ derivative and the redox potential of the 
0,/O; couple (-0.16 V, Ref. (28)) and is given by the 
equilibrium constant K (29): 
K = [O,l [BABQI = ,38.94(-0.16-E1,2) 
P,l PABQ;l 
[51 
For BABQ derivatives having a more positive redox 
potential (BABQ/BABQ:) than the oxygen/superoxide 
couple, the equilibrium is on the side of semiquinone. K- 
values were computed using Eq. [5] (Table III). Half- 
wave potentials in Tables II and III are determined as 
two-electron reduction potentials (18), whereas one- 
electron reduction potentials are relevant in Eqs. [4] and 
[5]. In water, however, the difference between these val- 
ues is small (30,31). 
Addition of SOD will lead to a decrease in superoxide 
concentration, by enhancement of the dismutation rate 
of superoxide. As a result, Eq. [4] will shift to the side of 
0; and the concentration of BABQ; will decrease. The 
cytochrome c reduction rate, which is dependent on 
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H202 + 02 
FIG. 6. Routes of electron transport from xanthine oxidase to cyto- 
chrome c in the presence of a BABQ derivative and oxygen. X, xan- 
thine; X0, xanthine oxidase; Q, Q;, and Q’- are the oxidized and the 
one- and two-electron reduced BABQ species, respectively. 
both 0, and BABQ: will decrease (see Fig. 6). In our 
experiments, we observe that higher amounts of SOD 
are needed to inhibit cytochrome c reduction when 
BABQ derivatives are present than without BABQ. The 
amount of SOD needed for inhibition of cytochrome c 
reduction increases when the reduction potential of the 
BABQ derivative is more positive, and the K-value (Eq. 
[4]) is smaller (Table III). This indicates, even though 
one has to take into account that BABQ derivatives re- 
act more efficiently with cytochrome c than superoxide, 
that the greatest part of the reducing equivalents from 
xanthine go to BABQ;, especially when the redox poten- 
tial of BABQ is more positive. This is explained both by 
the high reduction rate of the BABQ derivatives and by 
the position of the equilibrium (Eq. [4]). 
A similar explanation for the effect of SOD on cyto- 
chrome c reduction was provided by Winterbourn (32), 
who studied this effect with a series of methyl-substi- 
tuted and sulfonated quinone derivatives. 
In summary, we conclude that aziridinylbenzoqui- 
nones are efficient electron acceptors from xanthine oxi- 
dase. The rate of reduction of these compounds by xan- 
thine oxidase depends on the redox potential and the 
size of the molecule. At quinone concentrations > 25 PM 
quinone reduction by xanthine oxidase prevails over ox- 
ygen reduction. Therefore, reduction by xanthine oxi- 
dase is an efficient and simple method to study forma- 
tion of reactive oxygen intermediates formed by reduced 
aziridinylbenzoquinones. Measurement of the part of 
the cytochrome c reduction rate under air that is inhib- 
ited by SOD does not reflect the production of superox- 
ide. We fully subscribe to the warning of Winterbourn 
(32), that SOD effects, when used to demonstrate the 
involvement of superoxide, should be interpreted with 
caution. The results of this study will be used to investi- 
gate the formation of reactive oxygen intermediates and 
DNA damage by reduced BABQ derivatives. 
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